Anti-CXCL13 antibodies for treating autoimmune diseases and cancer

Compositions and methods for growth factor modulation

Antibodies against species

Antibody drug conjugates (ADC) that bind to 191P4D12 proteins

Anti-PSMA antibodies and use thereof

CD38 modulating antibody agents

CD70 binding molecules and methods of use thereof

Antibodies that bind chemokine (C-C motif) receptor 8 (CCR8)

Single-domain antibodies against CLL1 and constructs thereof

Anti-PD-L1 antibody

BTLA antibodies

Anti-PD-1 antibodies

Anti-TCR antibody molecules and uses thereof

CONSTRUCTS TARGETING AFP PEPTIDE/MHC COMPLEXES AND USES THEREOF

NATIVE HUMAN ANTIBODIES FOR IMMUNE CHECKPOINT MODULATION TARGETS TIM-3 AND B7-H3

Anti-SIRP-Beta1 antibodies and methods of use thereof

Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses

Anti-ROR1 antibodies and methods of making and using thereof

Epitope specific antibodies that bind cell surface GRP78 and their use for cancer detection

Methods of treatment with anti-PACAP antibodies

TGFβ antibodies, methods and uses

Anti-complement factor C1Q antibodies and uses thereof

IMMUNOCONJUGATES TARGETING ADAM9 AND METHODS OF USE THEREOF

Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders

Single-domain antibodies against CD33 and constructs thereof

Anti-glyco-MUC1 antibodies and their uses

ANTI-GITR ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF

Anti-mesothelin chimeric antigen receptor (CAR) constructs and uses thereof

ANTI-C-MET ANTIBODY AND USES THEREOF

Anti-TrkB agonist antibodies binding to D1 domain of TrkB

Anti-PD-L1 antibodies

Agent, uses and methods for treatment

Variable regions for NKp46 binding proteins

BISPECIFIC ANTIBODY AND USE THEREOF

Anti-human CD19 antibodies

Partial agonists of interleukin-2

Notch receptors with hinge domain

METHOD FOR IMPROVING AFFINITY OF ANTIBODY FOR ANTIGEN AND USE THEREOF

Anti-human VSIG4 antibodies and uses thereof

Anti-BAFF receptor antibodies and uses thereof

ANTI-FLT-1 ANTIBODIES IN TREATING BRONCHOPULMONARY DYSPLASIA

FLT3 binding proteins and methods of use

NOVEL ANTI-BMPR1B ANTIBODIES AND METHODS OF USE

PROTEINS BINDING NKG2D, CD16, AND EGFR, CCR4, OR PD-L1

Blocking type PD-L1 single-domain camel antibody and application thereof

Human antibodies that bind Lymphocyte Activation Gene-3 (LAG-3), and uses thereof

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

ANTICARBOXYMETHYL LYSINE ANTIBODIES AND ULTRASOUND FOR REMOVING AGE-MODIFIED CELLS

METHODS AND COMPOSITIONS FOR TREATING DISEASE-RELATED CACHEXIA

Human CD163 antibodies and uses thereof

Humanized anti-CD73 antibodies

Nucleic acid molecules encoding binding agents to CD40 and 4-1BB (CD137)

NOVEL BISPECIFIC AGONISTIC 4-1BB ANTIGEN BINDING MOLECULES

Anti-NGF Antibodies and Methods Thereof

ALK2 ANTIBODIES AND METHODS OF USE THEREOF

FRIZZLED5 PROTEIN-BINDING AGENTS

Anti-ACVR1 antibodies and uses thereof

ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE

PD-L 1-BINDING POLYPEPTIDE AND USE THEREOF

MULTI-SPECIFIC ANTIBODY CONSTRUCTS

Optimized Anti-CD3 Bispecific Antibodies and Uses Thereof

Anti-CD112R compositions and methods

Nucleic acids encoding antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)

ANTI-TIGIT ANTIBODIES AND METHODS OF USE

Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use

Single domain antibodies for complement regulation

Methods and compositions for increasing iduronate 2-sulfatase activity in the CNS

Anti-yellow fever antibodies, and methods of their generation and use

Anti-TIM-3 antibodies and methods of use thereof

MODIFIED GAMMA DELTA T CELLS AND USES THEREOF

MULTISPECIFIC MOLECULES THAT BIND TO MYELOPROLIFERATIVE LEUKEMIA (MPL) PROTEIN AND USES THEREOF

Anti-TMPRSS2 antibodies and antigen-binding fragments

NOVEL ANTI-PAD2 ANTIBODY

ANTI-HER3 Antibody and uses thereof

Humanized anti-CD137 antibodies and uses thereof

TRIMERIC POLYPEPTIDE COMPLEXES AND USES THEREOF

Antitumor antagonists

Anti-E-selectin antibodies, compositions and methods of use

Anti-BTLA antibody

Antibodies Comprising Chimeric Constant Domains

Anti-Siglec-7 antibodies and methods of use thereof

Treatment or prevention of diseases and disorders associated with cells that express IL-6 with Anti-IL-6 antibodies

Immune-stimulating humanized monoclonal antibodies against human interleukin-2, and fusion proteins thereof

Multiple specificity binders of CXC chemokines

Methods of isolating allergen-specific antibodies from humans and uses thereof

NOVEL ANTIGEN BINDING DIMER-COMPLEXES, METHODS OF MAKING/AVOIDING AND USES THEREOF

ANTI-CD3 ANTIBODIES AND METHODS OF USE

MRNA display antibody library and methods

Antibodies and chimeric antigen receptors specific for ROR1

ANTIGEN-BINDING MOLECULE SHOWING CHANGED HALF-LIFE IN CYTOPLASM

Eribulin antibody-drug conjugates and methods of use

ANTI-TROP2 ANTIBODY-DRUG CONJUGATE

HIGH AFFINITY MONOCLONAL ANTIBODIES (MABS) AGAINST CELL SURFACE EXPRESSED HUMAN CARBONIC ANHYDRASE IX (HCA-IX), AND USES THEREOF

ANTI-CD137 ANTIBODIES

Polypeptides

Anti-CCR8 antibodies and uses thereof

MULTISPECIFIC ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTIBODIES AND METHODS OF USING THE SAME

PROTEINS BINDING NKG2D, CD16 AND P-CADHERIN

Anti-VLA-4 antibodies having reduced effector function

MULTI-SPECIFIC BINDING PROTEINS AND METHODS OF USE THEREOF

Treatment regimens using anti-NKG2A antibodies

Multifunctional molecules that bind to calreticulin and uses thereof

Antibodies to human ZnT8

Glucose transporter 4 antibodies, methods of making the same, and uses thereof

Anti-TNF antibodies, compositions, and methods for the treatment of active Ankylosing Spondylitis

ANTIBODY MOLECULES TO COMPLEMENT COMPONENT 5 AND USES THEREOF

Human Anti-Tau Antibodies

Therapeutic targeting of non-cellular structures

Anti-O2 antibodies and uses thereof

Potent zika virus-specific and cross-neutralizing monoclonal antibodies to zika and dengue viruses following ZIKV infection or vaccination

Monoclonal antibody that binds a MERS-coronavirus

Methods and compositions for targeting disease related cell surface receptors using radiolabeled and/or cytotoxin labelled antibodies

AGENTS, USES AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHY

Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies

Targeted Self-Assembly of Functionalized Carbon Nanotubes on Tumors

Anti-lambda myeloma antigen (LMA) binding proteins to treat LMA-expressing cancer and autoimmune disorders

METHOD FOR IMPROVING AFFINITY OF ANTIBODY FOR ANTIGEN AND USE THEREOF

METHOD FOR IMPROVING AFFINITY OF ANTIBODY FOR ANTIGEN AND USE THEREOF

METHOD FOR IMPROVING AFFINITY OF ANTIBODY FOR ANTIGEN AND USE THEREOF

METHOD FOR IMPROVING AFFINITY OF ANTIBODY FOR ANTIGEN AND USE THEREOF

ANTI-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS

DIMERIC PROTEIN WITH TRIPLE MUTATIONS

MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIA

Anti-CD73 antibodies and uses thereof

TARGETED ENGINEERED INTERFERON AND USES THEREOF

Muscle targeting complexes and uses thereof for treating dystrophinopathies

Monoclonal antibody against human 4-1BB, method for preparing the same, and use thereof

MULTISPECIFIC ANTIBODIES, COMPOSITIONS COMPRISING THE SAME, AND VECTORS AND USES THEREOF

Monoclonal antibody anti-FGFR4

Neutralizing antibodies to the alpha v beta 8 integrin complex for immunotherapy

Antibodies binding to HLA-A2/MAGE-A4

Anti-PD1 antibodies and their use as therapeutics and diagnostics

Humanized anti-CD200 antibodies and uses thereof

Antibody targeting CLDN18.2, bispecific antibody, ADC, and CAR, and applications thereof

Anti-thyroid hormone (T4) recombinant antibody or antigen binding fragment

IMMUNE-STIMULATING MONOCLONAL ANTIBODIES AGAINST HUMAN INTERLEUKIN-2

Anti-human interleukin 17A monoclonal antibody and application thereof

Anti-IL-22 antibodies, antibody fragments, their immunoconjugates and uses thereof

Human immunodeficiency virus neutralizing antibodies and methods of use thereof

Multi-specific molecules

Antibodies, pharmaceutical compositions and methods

ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS

Immune complex

High-affinity anti-VEGF antibody KLHa505

Inhibition of oxidation-specific epitopes to treat ischemic reperfusion injury

UNIVERSAL OR NORMALIZED ANTIBODY FRAMEWORKS FOR IMPROVED FUNCTIONALITY AND MANUFACTURABILITY

Antibody beneficial for treatment of solid tumors, antibody-drug conjugate, and cancer drug including same

Anti-MUC1 antibody

ANTI-CD73 ANTIBODIES

CD137 antibodies and PD-1 antagonists and uses thereof

Method of treating IgA nephropathy by administering altered antibodies which bind human a proliferation-inducing ligand (APRIL) protein

Canine anti-NGF antibodies and methods of treating pain thereof

Methods of treating myelodysplastic syndrome and acute myeloid leukemia with nonfucosylated anti-CD70 antibodies

Methods of treating severe insulin resistance by interfering with glucagon receptor signaling

IL13Rα2 binding agents and use thereof

PROTEINS BINDING NKG2D, CD16 AND AN ANTIGEN ASSOCIATED WITH TUMORS, MDSCS AND/OR TAMS

Single-domain antibodies and variants thereof against PD-L1

Antibody binding TIM-3 and use thereof

Human anti-IFN-α antibodies

Antibody against advanced glycation end products and use thereof

Antibodies to alpha-synuclein and uses thereof

Anti-complement factor Bb antibodies and uses thereof

Ebola virus antibodies and binding agents derived therefrom

Hepatitis B antibodies

Interleukin-2 and use thereof

Muscle targeting complexes and uses thereof for treating myotonic dystrophy

Antibodies specific to human t-cell immunoglobulin and ITIM domain (TIGIT)

BCMA monoclonal antibody-drug conjugate

ANTIBODY MOLECULES TO CD73 AND USES THEREOF

Anti-human 4-1BB antibodies and uses thereof

ANTI-CD40 ANTIBODIES AND COMPOSITIONS

Anti-OX40 antibodies and methods of use

Felinized anti-NGF antibodies and methods of treating pain

Anti-NGF Antibodies and Methods Thereof

Methods of treating a canine and inhibiting NGF activity through use of anti-NGF antibodies

Dual specificity antibodies to PD-L1 and PD-L2 and methods of use therefor

VARIANTS WITH FC FRAGMENT HAVING AN INCREASED AFFINITY FOR FCRN AND AN INCREASED AFFINITY FOR AT LEAST ONE RECEPTOR OF THE FC FRAGMENT

CLDN 18.2-specific monoclonal antibodies and methods of use thereof

DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) IN PEDIATRIC PATIENTS

Anti-gliadin antibodies, encoding nucleic acids and methods of detecting gliadin

Compositions and methods for imaging

Humanized monoclonal advanced glycation end-product antibody

Therapeutic antibodies against ROR-1 protein and methods for use of same

Masked activatable CD137 antibodies

Proteins specific for BAFF and B7RP1 and uses thereof

Enhanced targeting platform

Antibodies against BACE1 and use thereof for neural disease immunotherapy

DPP3 binder directed to and binding to specific DPP3-epitopes and its use in the prevention or treatment of diseases / acute conditions that are associated with oxidative stress

Compositions and methods for the depletion of CD117+ cells

Anti-Jagged2 antibodies and methods of use

Method of reducing expression of DUX4 in a muscle cell by administering an anti-transferrin receptor antibody linked to an oligonucleotide targeting DUX4

Anti-CTLA4 antibodies and methods of making and using the same

LAG-3-binding molecules and methods of use thereof

Blocking antibodies against CD47 and methods of use thereof

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Antibodies and antibody fragments against HNAV1.7 channel and their use in pain and cancer indications

Antibody compositions for disrupting biofilms

EGFR and C-met fibronectin type III domain binding molecules

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions

Animal models and therapeutic molecules

Direct affinity measurement of human IgG1 binding multimeric antigens

Methods to create chemically-induced dimerizing protein systems for regulation of cellular events

Fusion proteins comprising enzyme replacement therapy enzymes

Method for determining the in vivo interaction mode

Humanized anti-NGF antibodies and methods of treating pain thereof

Multi-specific binding proteins that bind HER2, NKG2D, and CD16, and methods of use

MULTISPECIFIC MOLECULES TARGETING CLL-1

Anti PD-1 antibodies

Monoclonal antibodies against human tim-3

Anti-TNF-alpha-antibodies and functional fragments thereof

Antibody-based molecules specific for the truncated ASP421 epitope of Tau and their uses in the diagnosis and treatment of tauopathy

IL-2R-βγ binding compounds

METHODS OF QUANTIFYING LIF AND USES THEREOF

Catabodies and methods of use thereof

Methods for inhibiting angiogenesis in a subject in need thereof

Anti-doublecortin-like kinase 1 antibodies and methods of use

Antibodies against HPA-1a

Methods of using bispecific antigen-binding constructs targeting HER2

Human monoclonal antibodies to ganglioside GD2

Bispecific antigen binding molecules capable of specific binding to CD40 and to fap

Therapeutic antibodies and their uses

Anti-4-1BB antibodies and methods of making and using thereof

Nucleic acids encoding a canine antibody which binds nerve growth factor and vectors and host cells thereof

Method of eliminating hematopoietic stem cells/hematopoietic progenitors (HSC/HP) in a patient using bi-specific antibodies

Humanized, mouse or chimeric anti-CD47 monoclonal antibodies

Anti-PVRIG antibodies and methods of use

Leptin antibodies

Antibodies that bind interleukin-2 and uses thereof

IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases

Medical device for administering anti-IL-23 antibodies

Anti-transthyretin antibodies

Antibody neutralizing human respiratory syncytial virus

Antibodies against F glycoprotein of Hendra and Nipah viruses

ANTI-MUC1 ANTIBODY-DRUG CONJUGATE

Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said molecules

Trispecific binding proteins and methods of use

Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same

Anti-STEAP1 antigen-binding protein

Antibodies for treatment of cancer expressing claudin 6

Antibodies against CDCP1 for the treatment and detection of cancer

Modified bifunctional anti-human signal regulatory protein alpha (SIRPa) antibody and method of use thereof for treating cancer

Anti-CD27 antibodies and use thereof

VARIANT NUCLEIC ACID LIBRARIES FOR ADENOSINE RECEPTORS

Human CGRP receptor binding proteins

Human CGRP receptor binding proteins

Antibody binding to Tie2 and use thereof

Antibodies specific for CD47, PD-L1, and uses thereof

Anti-Ly6G6D antibodies and methods of use

Binding proteins to the human thrombin receptor, PAR4

Anti-IL-1β antibody and pharmaceutical composition thereof and use of same

METHODS OF TREATING AUTO-INFLAMMATORY SYNDROMES USING IL-1BETA ANTIBODIES

Methods and compositions for PDGF-CC inhibition

Antibodies to alpha-synuclein and uses thereof

Anti-PHF-tau antibodies and uses thereof

Fc VARIANTS THAT IMPROVE FcRn BINDING AND/OR INCREASE ANTIBODY HALF-LIFE

Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodies

Stable antibody-drug conjugate, preparation method therefor, and use thereof

ANTIGEN BIOMARKER OF MICROSATELLITE INSTABILITY

IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS

IN VITRO TRANSCYTOSIS ASSAY

Production of T cell retargeting hetero-dimeric immunoglobulins

TARGETED DELIVERY METHODS AND COMPOSITIONS FOR ANTIHISTAMINES

FGF21 mimetic antibodies and uses thereof

HUMAN ANTIBODIES AGAINST TISSUE FACTOR AND METHODS OF USE THEREOF

Anti-SIRP-alpha antibodies and related methods

Fusion proteins and antibodies targeting human red blood cell antigens

B cell maturation antigen binding proteins

Anti-vista antibodies and fragments, uses thereof, and methods of identifying same

ANTIBODIES TO PROGRAMMED DEATH LIGAND (PD-L1) AND APPLICATION THEREOF

Antibodies to ICOS

Bispecific CD16-binding molecules and their use in the treatment of disease

Anti-claudin 18.2 antibodies and uses thereof

Anti-notch3 antibodies

NOVEL ANTIBODY FORMAT

Method of treating ocular conditions by administering an antibody that activates Tie2 and binds VEGF

CLOSTRIDIUM DIFFICILE-SPECIFIC ANTIBODIES AND USES THEREOF

Antibodies and methods for the diagnosis, prevention, and treatment of Epstein Barr virus infection

Fusion protein binding to CD47 protein and application thereof

MULTI-DOMAIN PROTEINS WITH INCREASED NATIVE STATE COLLOIDAL STABILITY

BINDING FUSION PROTEINS, BINDING FUSION PROTEIN-DRUG CONJUGATES, XTEN-DRUG CONJUGATES AND METHODS OF MAKING AND USING SAME

MICE THAT MAKE VL BINDING PROTEINS

Antibody variants and uses thereof

APJ antibody, fusion protein thereof with Elabela, and pharmaceutical compositions and use thereofus01

Antibody therapeutics that bind CD123

High affinity human antibodies to human IL-4 receptor

Therapeutic compositions comprising anti-NRP2 antibodies

ASGR INHIBITORS

PD-L1 BINDING AFFIMERS, AND USES RELATED THERETO

Anti-TIM-3 antibodies

Interferon beta antibodies and uses thereof

Anti-IL31 antibodies for veterinary use

Bone-targeting antibodies

ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF

Antibodies to R-spondin 3

HIGH-AFFINITY MYCOBACTERIUM TUBERCULOSIS CAPSULE-SPECIFIC HUMAN MONOCLONAL ANTIBODY

Fc VARIANTS THAT IMPROVE FcRn BINDING AND/OR INCREASE ANTIBODY HALF-LIFE

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

Gene therapy constructs and methods of use